AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Sep 11 2023
The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach Americans within days as U.S. hospitalizations from the virus rise.
The new vaccines, which target the omicron variant XBB.1.5, are approved for people 12 and older and are authorized under emergency use for children 6 months through 11 years old,CNBC
Sep 12 2023
Covid-19 boosters formulated to protect against newer strains of the virus won backing from a panel of US health advisers, a crucial step for public use amid an increase in cases. The advisory group recommended that the US Centers for Disease Control and Prevention approve the shot from Moderna Inc. and Pfizer Inc. and BioNTech SE for use in those six months and older by a vote of 13-1. CDCBloomberg
Mar 22 2023
Moderna is expected to charge about $130 for a single dose of its COVID-19 vaccine once the U.S. government stops buying the shots, according to Reuters.
"There are different customers negotiating different prices right now, which is why it's a little bit complicated," president Stephen Hoge told Reuters on Monday during an interview.
Hoge made his comments two days beforeFox Business
Mar 22 2023
The Biden administration quietly inserted itself into a private patent infringement lawsuit two biotech companies filed against COVID-19 vaccine maker Moderna, in a move experts said could establish a dangerous precedent.
In a surprise filing last month, U.S. Attorney David Weiss issued a "statement of interest" in the case on behalf of the Department of Defense and Department ofFox News (Online News)
Dec 07 2020
Moderna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273. A clinical trial demonstrated that the vaccine has an efficacy rate of 94.1 percent in preventing Covid-19.New York Times (News)
May 21 2020
This Abridge News topic aggregates four unique arguments on different sides of the debate. Here are the quick facts to get you started:
THE QUICK FACTSOn Monday, biotech company Moderna Therapeutics announced in a press release "positive" interim phase 1 data for a COVID-19 vaccine trial. Moderna's stock valuation subsequently surged.The company only disclosed Abridge News
Aug 26 2022
Moderna said it is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine.
The US drug company is alleging that mRNA technology it developed before the pandemic was copied.
The lawsuit, which is seeking unspecified financial damages, was filed in the US and Germany.
Pfizer said the company had not yet receivedBBC News
Oct 03 2023
The COVID vaccine rollout will soon include a third option, after the Food and Drug Administration on Tuesday authorized an updated Novavax shot for emergency use in individuals 12 years of age and older.
Why it matters: Novavax's product will be the only non-mRNA COVID-19 vaccine available in the U.S. and could potentially ease logistical issues that have disrupted the rollout amid aAxios
Oct 02 2023
American scientists Katalin Karikó (a Hungarian-born biochemist) and Drew Weissman (an immunologist and professor of vaccine research) have been awarded the Nobel Prize in Physiology or Medicine for their research on messenger ribonucleic acid (mRNA), which contributed towards the development of effective covid-19 vaccines (seen via The New York Times). mRNA vaccines have an advantage overThe Verge
Dec 29 2020
Moderna’s mRNA vaccine is the second COVID-19 vaccine authorized for use in the U.S. Here, we give a rundown of basic facts about the vaccine and an overview of how it works.
Quick Summary Vaccine name: mRNA-1273
Design type: mRNA
Dose number: 2 doses, 28 days apart
Efficacy: 94.1% efficacy in preventing symptomatic COVID-19 in adults two weeks or more after receiptFactCheck.org